Isida Byku

ORCID: 0000-0002-3951-6368
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Arrhythmias and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac pacing and defibrillation studies
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Aortic Disease and Treatment Approaches
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Issues in Pregnancy
  • Atrial Fibrillation Management and Outcomes
  • Nutrition, Health and Food Behavior
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Streptococcal Infections and Treatments
  • Congenital Heart Disease Studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Radiation Dose and Imaging
  • Coronary Interventions and Diagnostics
  • Central Venous Catheters and Hemodialysis
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention

Emory University
2019-2025

Emory University Hospital Midtown
2020-2025

Valve (United States)
2020-2025

Emory University Hospital
2019-2024

National Heart Lung and Blood Institute
2022

National Institutes of Health
2022

Washington Hospital
2019

University of Chicago
2017

University of Illinois Chicago
2017

University of Chicago Medical Center
2017

Radiation exposure during invasive cardiovascular procedures remains an important health care issue. Lead aprons and shields (LAS) are used to decrease radiation but leave large portions of the body unshielded. The Rampart IC M1128 is a portable shielding system that may significantly attenuate exposure.

10.1016/j.jscai.2023.101184 article EN cc-by Journal of the Society for Cardiovascular Angiography & Interventions 2024-01-01

Abstract Objectives We sought to evaluate the safety, efficacy and feasibility of same‐day discharge after uncomplicated, minimalist TAVR. Background At start COVID‐19 pandemic, we created a (SDD) pathway conscious sedation, transfemoral (minimalist) TAVR help minimize risk viral transmission conserve hospital resources. Studies support that next‐day (NDD) for carefully selected patients following is safe feasible. There paucity data regarding safety SDD Methods In‐hospital 30 day outcomes...

10.1002/ccd.29453 article EN Catheterization and Cardiovascular Interventions 2020-12-31

Objective: Percutaneous vegetation debulking has been reported to treat tricuspid valve infective endocarditis (TVIE), but data on feasibility compared with conventional surgical strategies are limited. We aimed compare short-term outcomes of suction partial venovenous bypass open surgery in this population. Methods: This was a single-center, retrospective study that included all patients isolated TVIE who underwent or between January 2010 and December 2022. Patient characteristics,...

10.1177/15569845241298283 article EN Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery 2025-01-24

Background: Intentional laceration of the anterior mitral leaflet (LAMPOON) is an effective adjunct to transcatheter valve replacement that prevents left ventricular outflow tract (LVOT) obstruction. To date, LAMPOON has been performed in over 150 patients using a retrograde approach can be technically challenging. A modified antegrade transseptal technique may simplify procedure. Methods: Antegrade was developed and tested nonsurvival pig experiments. Thereafter, at prohibitive risk LVOT...

10.1161/circinterventions.119.008903 article EN Circulation Cardiovascular Interventions 2020-06-01

Importance Historically, women with aortic stenosis have experienced worse outcomes and inadequate recognition compared to men, being both underdiagnosed undertreated, while also facing underrepresentation in clinical trials. Objective To determine whether small annuli undergoing transcatheter valve replacement better hemodynamic a self-expanding (SEV) or balloon-expandable (BEV). Design, Setting, Participants The Small Annuli Randomized Evolut SAPIEN Trial (SMART) was large-scale randomized...

10.1001/jamacardio.2024.3241 article EN JAMA Cardiology 2024-10-09

Valve-in-valve (ViV) transcatheter aortic valve replacements (TAVRs) are being performed more frequently in patients with degenerated bioprosthetic AVRs at high-risk for redo surgery. Antiplatelet (AP) and anticoagulation (AC) strategies after these procedures not well established. This study examines changes mean gradients (MG) on different antithrombotic following ViV TAVR. Patients undergoing TAVRs from January 1, 2019 to December 31, 2022 our center were included. Changes...

10.1016/j.jscai.2023.100760 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2023-05-01

Transcatheter pulmonary valve replacement (TPVR) in patients with a congenital or acquired abnormality resulting enlarged right ventricular outflow tract (RVOT) is challenging and may preclude treatment dedicated devices. We describe technique using physician-modified endograft to facilitate TPVR.Six underwent endograft-facilitated TPVR for severe symptomatic insufficiency RVOT. The fenestration was created commercially available before implantation, which then deployed from the dominant...

10.1161/circinterventions.123.013123 article EN Circulation Cardiovascular Interventions 2023-08-14

Postinfarction ventricular septal defect (VSD) is a catastrophic complication of myocardial infarction. Surgical repair still has poor outcomes. This report describes clinical outcomes after novel hybrid transcatheter/surgical in patients with apical VSD.

10.1161/circinterventions.123.013243 article EN Circulation Cardiovascular Interventions 2023-09-21
Coming Soon ...